Genetic and non-genetic theories on the etiology of polycystic ovary syndrome

Gynecological Endocrinology

Volumn 10, Issue 5, 1996, Pages 357-364

  Jahanfar, S ^a   Eden, J A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Etiology; IGF I; Polycystic ovary syndrome

Indexed keywords

FOLLITROPIN; GONADORELIN; GROWTH HORMONE; LUTEINIZING HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ENVIRONMENTAL FACTOR; FEEDING; FETUS GROWTH; GENE MUTATION; GENETIC ANALYSIS; GROWTH HORMONE RELEASE; HIRSUTISM; HUMAN; KARYOTYPE; NONHUMAN; OLIGOMENORRHEA; OVARY FOLLICLE FLUID; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; PRIORITY JOURNAL; REVIEW; X CHROMOSOME LINKAGE;

EID: 0029988292     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599609012823     Document Type: Review

References (67)

1. Stein, I. F. and Leventhal, M. L. (1935). Amenorrhea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol., 29, 181-91
2. Barnes, R. B., Rosenfield, R. L., Burstein, S. and Ehrmann, D. A. (1989). Pituitary-ovarian responses to nafarelin in the polycystic ovary syndrome. N. Engl. J. Med., 320, 559-65
3. 5-steroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab., 76, 450-5
4. Compo, S., Felli, A., Lamanna, M. A., Barini, A. and Garcea, N. (1993). Endocrine changes and clinical outcome after laparoscopic ovarian resection in women with polycystic ovaries. Hum. Reprod., 8, 359-63
5. Stewart, P. M., Shackleton, C. H. L., Beastall, G. H. and Edwards, C. R. W. (1990). 5α-Reductase activity in polycystic ovary syndrome. Lancet, 335, 431-3
6. Gelderen, C. J. V. and Comes dos Santos, M. L. L. (1993). Polycystic ovary syndrome. Evidence for an autoimmune mechanism in some cases. J. Reprod. Med., 38, 381-6
7. Carey, A. H., Chan, K. L., Short, F., White, D., Williamson, R. and Franks, S. (1993). Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin. Endocrinol. (Oxf.), 38, 653-8
8. Dowse, G. (1993). The thrifty genotype in non-insulin dependent diabetes. The hypothesis survives. Br. Med. J., 306, 532-5
9. Hague, W. M. and Millar, D. R. (1985). Excessive testosterone secretion in pregnancy. Case report. Br. J. Obstet. Gynaecol., 92, 173-8
10. Kadylak, B. and Janowiak, Z. (1991). Degenaratio cystica ovarii neonatorum. Zentralbl. Gynakol., 113, 285-9
11. Mulaikal, R. M., Migeon, C. J. and Rock, J. A. (1987). Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N. Engl. J. Med., 316, 178-82
12. Insler, V. and Lunenfeld, B. (1991). Pathophysiology of polycystic ovarian disease: new insights. Hum. Reprod., 6, 1025-9
13. Phillips, K., Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C. and Clark, P. M. S. (1993). Fetal growth and impaired glucose tolerance in men and women. Diabetologia, 36, 225-8
14. Jahanfar, S., Eden, J. A., Warren, P., Seppala, M. and Nguyent, T. V. (1995). A twin study of polycystic ovary syndrome. Fertil. Steril., 63, 478-86
15. Kazer, R. (1989). The aetiology of polycystic ovary syndrome (PCO). Med. Hypotheses, 30, 151-5
16. Mechanick, J. I. and Futterweit, W. (1984). Hypothesis: aberrant puberty and the Stein-Levanthal syndrome. Int. J. Fertil., 29, 35-8
17. Orenstein, H. and Raskind, M. A. (1983). Polycystic ovary disease in two patients with Briquet's disorder. Am. J. Psychiatry, 140, 1202-4
18. McCluskey, S., Evans, C., Lacey, J. H., Pearce, J. M. and Jacobs, H. (1992). Polycystic ovary syndrome and bulimia. Fertil. Steril., 55, 287-91
19. McCluskey, S. E., Lacey, J. H. and Pearce, J. M. (1992). Binge-eating and polycystic ovaries [letter]. Lancet, 340, 723
20. Killen, J. D., Hayward, C., Litt, I., Hammer, L. D., Wilson, D. M., Miner, B., Taylor, C. B., Varady, A. and Shisslak, C. (1992). Is puberty a risk factor for eating disorders? Am. J. Dis. Child., 146, 323-5
21. Yen, S. S. C. (1980). The polycystic ovary syndrome. Clin. Endocrinol. (Oxf.), 12, 177-208
22. Dewailly, D. and Coetet-Rudelli, C. (1992). Insulin resistance and polycystic ovarian syndrome. Horm. Res., 38, 41-5
23. Obhria, M., Lynch, S. S., Holder, G., Jackson, R., Tang, L. and Butt, W. R. (1990). Hormonal studies on women with polycystic ovaries diagnosed by ultrasound. Clin. Endocrinol. (Oxf.), 32, 467-74
24. Puzigaca, Z., Prelevic, G. M., Stretenoric, Z. and Balint-Peric, L. (1991). Ovarian enlargement as a possible marker of androgen activity in polycystic ovary syndrome. Gynecol. Endocrinol., 5, 167-74
25. Rittmaster, R. S. and Thompson, D. L. (1990). Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J. Clin. Endocrinol. Metab., 70, 1096-102
26. Ehrmann, D. A., Rosenfield, R. L., Barnes, R. B., Brigell, D. F. and Sheikh, Z. (1992). Detection of functional ovarian hyperandrogenism in women with androgen excess. N. Engl. J. Med., 327, 157-62
27. Cedars, M. I., Steingold, K. A., de Ziegler, D., Lapolt, P. S., Chang, R J. and Judd, H. L. (1992). Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction. Fertil. Steril., 57, 495-500
28. Polson, D. W., Adams, J., Steen, P. J. and Franks, S. (1986). Unilateral polycystic ovary. Case report. Br. J. Obstet. Gynaecol, 93, 1110-3
29. Hammond, J. M., Baranao, J. L. S., Skaleris, D., Knight, A. B., Romanus, J. A. and Matthew, M. R. (1985). Production of insulin-like growth factors by ovarian granulosa cells. Endocrinology, 117, 2553-5
30. Adashi, E. Y., Resnick, C. E., Brodie, A. M. H., Svoboda, M. E. and Van Wyk, J. (1985). Somatomedin-C mediated potentiation of follicle stimulating hormone induced aromatase activity of cultured rat granulosa cells. Endocrinology, 117, 2313-20
31. Adashi, E. Y., Resnick, C. E., Hernandez, E. R., May, J. V., Knecht, M., Svobodo, M. E. and Wyk, J. J. V. (1988). Insulin-like growth factor-I as an amplifier of follicle-stimulating hormone action: studies on mechanism(s) and side(s) of action in cultured rat granulosa cells. Endocrinology, 122, 1583-91
32. Erickson, G. F., Magoffin, D. A., Cragun, J. R. and Chang, R.J. (1990). The effects of insulin and insulin-like growth factor-I and II on estradiol production by granulosa cells of polycystic ovaries. J. Clin. Endocrinol. Metab., 70, 894-902
33. Hernandez, E. R., Roberts, C. T., Hurwitz, A., LeRoith, D. and Adashi, E. Y. (1990). Rat ovarian insulin-like growth factor II gene expression is theca-interstitial cell-exclusive: hormonal regulation and receptor distribution. Endocrinology, 127, 3249-51
34. Insler, V., Shoham, Z., Barash, A., Koistinen, R., Seppälä, M., Hen, M., Lunenfeld, B. and Zadik, Z. (1993). Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings. Hum. Reprod., 8, 379-83
35. Mondschein, J. S., Smith, S. A. and Hammond, J. M. (1990). Production of insulin-like growth factor binding proteins (IGFBPs) by porcine granulosa cells: identification of IGFBP-2 and -3 and regulation by hormones and growth factors. Endocrinology, 127, 2298-306
36. Suikkari, A. M., Ruutiainen, K., Erkkola, R. and Seppälä, M. (1989). Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease. Hum. Reprod., 4, 136-9
37. Conway, G. S., Jacobs, H. S., Holly, J. M. P. and Wass, J. A. H. (1990). Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome. Clin. Endocrinol. (Oxf.), 33, 593-603
38. Pekonen, F., Laatikainen, T., Buyalos, R. and Rutanen, E. M. (1989). Decreased34K insulin-like growth factor binding protein in polycystic ovarian disease. Fertil. Steril., 51, 972-5
39. Gataldo, N. A. and Giudice, L. C. (1992). Follicular fluid insulin-like growth factor binding protein profiles in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 74, 695-7
40. Gospodarwicz, D. and Bialecki, H. (1979). Fibroblast and epidermal growth factors as mitogenic agents for cultured granulosa cells of rodent, porcine and human origin. Endocrinology, 104, 757-64
41. Mason, H. D., Margara, R., Winston, R. M. L., Beard, R. W., Reed, M. J. and Franks, S. (1991). Inhibition of oestradiol production by epidermal growth factor in human granulosa cells of normal polycystic ovaries. Clin. Endocrinol. (Oxf.), 33, 511-17
42. Anaplitou, L. G., Syrigos, K., Panayiotakopoulos, G., Kalos, A. and Batrinos, M. L. (1989). Paradoxical growth hormone response following thyroidstimulating hormone administration in the polycystic ovarian syndrome. Horm. Res., 31, 119-24
43. Chang, R. J., Nakaruma, R. M., Judd, H. L. and Kaplan, S. A. (1983). Insulin resistance in nonobese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab., 57, 356-9
44. Lanzone, A., Fulghesu, A. M., Pappalardo, S., Proto, C., LeDonne, M. and Andreani, C. L. (1990). Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Gynecol. Obstet. Invest., 29, 149-53
45. Burghen, G. A., Givens, J. R. and Kitabchi, A. E. (1980). Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab., 50, 113-16
46. Urdle, W. (1988). Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C. Arch. Gynecol. Obstet., 243, 13-36
47. Cooper, H. E., Spellacy, W. N., Prem, K. A. and Cohen, W. D. (1968). Hereditary factors in the Stein-Leventhal syndrome. Am. J. Obstet. Gynecol., 100, 371-87
48. Givens, J. R., Andersen, R. N., Umstot, E. S. and Wiser, W. L. (1976). Clinical findings and hormonal responses in patients with polycystic ovarian disease with normal versus elevated LH levels. Obstet. Gynecol., 47, 388-94
49. Wilroy, R. S., Givens, J. R., Wiser, W. L., Coleman, S. A., Andersen, R. N. and Fish, S. A. (1962). Hyperthecosis, an inheritance form of polycystic ovary. I. Clinical and histologic features. J. Clin. Endocrinol. (Oxf.), 22, 326-8
50. Givens, J. R. (1988). Familial polycystic ovarian disease. Endocrinol. Metab. Clin. North Am., 17, 771-83
51. Ferriman, D. and Purdie, A. W. (1979). The inheritance of PCO and possible relationship to premature balding. Clin. Endocrinol. (Oxf.), 11, 771-83
52. Lunde, O., Magnus, P., Sandvik, L. and Hoglo, S. (1989). Familial clustering in the polycystic ovarian syndrome. Gynecol. Obstet. Invest., 28, 23-30
53. Hague, W. M., Adams, J., Reeders, S. T., Peto, T. E. A. and Jacobs, H. S. (1988). Familial polycystic ovaries: a genetic disease. Clin. Endocrinol. (Oxf.), 29, 593-605
54. Goldzieher, J. W. and Green, J. A. (1962). The polycystic ovary. I. Clinical and histologic features. J. Clin. Endocrinol. (Oxf.), 22, 325-38
55. Jeffcoate, T. N. A. (1964). The androgenic ovary, with special reference to the Stein-Leventhal syndrome. Am. J. Obstet. Gynecol., 88, 143-56
56. McDonough, P. G., Mahesh, V. B. and Ellegood, J. O. (1972). Steroid, follicle-stimulating hormone, and luteinizing hormone profiles in identical twins with polycystic ovaries. Am. J. Obstet. Gynecol., 113, 1072-6
57. Lee, P. A., Migeon, C. J., Bias, W. B. and Jones, G. S. (1987). Familial hypersecretion of adrenal androgens transmitted as a dominant, non-HLA linked trait. Obstet. Gynecol., 69, 259-65
58. Parker, R., Ming, P. L., Rajan, R., Goodner, D. M. and Reme, A. (1980). Clinical and cytological studies of patients with polycystic ovary disease. Am. J. Obstet. Gynecol., 137, 656-60
59. Zarate, A., Garcia-Reyes, J. A., Castelazo-Ayala, L., Estevez, R. and Silva, J. (1969). Turner's phenotype with menstruation, XO karyotype and germ cells in the ovary. Obstet. Gynecol., 33, 818-21
60. Williams, G. H., Rose, L. I., Jagger, P. I. and Lauler, D. P. (1969). A Turner's syndrome variant with polycystic ovaries and idiopathic myocardial hypertrophy. Ann. Intern. Med., 70, 571-6
61. Netter, A., Bloch-Michel, H., Salomon, Y., Thervet, F., de Grouchy, J. and Lamy, M. (1961). Study of karyotypes in Stein-Leventhal syndrome. Ann. Endocrinol. (Paris), 22, 841-9
62. Franks, S. (1989). Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol. (Oxf.), 31, 87-120
63. Surrey, E. S., de Ziegler, D., Lu, J. K. H., Chang, R. J. and Judd, H. L. (1989). Effects of gonadotropin-releasing hormone (GnRH) agonist on pituitary and ovarian responses to pulsatile GnRH therapy in polycystic ovarian disease. Fertil. Steril., 52, 547-52
64. Williams, I. A., Show, R. W. and Burford, G. (1989). An attempt to alter the pathophysiology of polycystic ovary syndrome using a gonadotropin hormone releasing hormone agonist - Nafarelin. Clin. Endocrinol. (Oxf.), 31, 345-53
65. Pang, S., Softness, B., Sweeney, W. J. and New, M. I. (1987). Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency. N. Engl. J. Med., 316, 1295-301
66. Winchester, B., Young, E., Geddes, S., Genet, S., Hurst, J., Middleton-Price, H., Williams, N., Webb, M., Habel, A. and Malcolm, S. (1992). Female twin with Hunter's disease due to nonrandom inactivation of the X chromosome: a consequence of twinning. Am. J. Med. Genet., 44, 834-8
67. Richards, C. S., Watkins, S. C., Hoffman, E. P., Schneider, N. R., Milsark, N. R. and Katz, K. S. (1990). Skewed X inactivation in a female MZ twin results in Duchenne muscular distrophy. Am. J. Hum. Genet., 46, 627-81